Skip to content

Growth and Tolerance of Young Infants

Growth and Tolerance of Young Infants Fed Amino Acid-Based Formulas

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03276884
Enrollment
267
Registered
2017-09-08
Start date
2017-10-11
Completion date
2018-11-08
Last updated
2018-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Growth

Brief summary

To compare growth and tolerance of healthy term infants fed two amino acid-based infant formulas.

Interventions

amino acid-based infant formula powder

amino acid-based infant formula powder

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
No minimum to 8 Days
Healthy volunteers
Yes

Inclusion criteria

* Subject is judged to be in good health. * Singleton from a full-term birth with a gestational age of 37 - 42 weeks. * Birth weight was ≥ 2490 g (\ 5 lbs. 8 oz.). * Subject is between 0 and 8 days of age at enrollment. * Parent(s) confirm their intention to feed their infant the study product as the sole source of nutrition for the duration of the study. * Parent(s) confirm their intention not to administer vitamin or mineral supplements (with the exception of Vitamin D-containing supplements), solid foods or juices to their infant from enrollment through the duration of the study. * Subject's parent(s) has voluntarily signed and dated an ICF prior to any participation in the study.

Exclusion criteria

* An adverse maternal, fetal or subject medical history that is thought by the investigator to have potential for effects on tolerance, growth, and/or development. * Subject is taking and plans to continue medications, home remedies, herbal preparations, prebiotics, probiotics or rehydration fluids that might affect gastrointestinal (GI) tolerance. * Subject participates in another study that has not been approved as a concomitant study.

Design outcomes

Primary

MeasureTime frameDescription
Weight GainStudy Day 14 to Study Day 119Infant scale

Secondary

MeasureTime frameDescription
GI toleranceStudy Day 1 to Study Day 119Parent completed questionnaires
LengthStudy Day 1 to Study Day 119Length board
Head CircumferenceStudy Day 1 to Study Day 119Measure tape
WeightStudy Day 1 to Study Day 119Infant scale

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026